Saframycin G
Saframycin G has the effect of anti-Gram-positive bacteria. Saframycin G has the effect of inhibiting mouse lymphocyte L-1210 with an ID50 of 0.03 μM[1].
Product Specifications
CAS Number
[92569-02-3]
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Cancer; Infection
Smiles
CC(C(NC[C@@H]1N2[C@](CC3=C1C(C(OC)=C(C3=O)C)=O)([H])[C@@]4([H])C5=C(C(C(C)=C(C5=O)OC)=O)[C@@H]([C@@](N4C)([H])[C@@H]2C#N)O)=O)=O
Molecular Formula
C29H30N4O9
Molecular Weight
578.57
References & Citations
[1]N Saito, et al. Synthesis of saframycins. X. Transformation of (-) -saframycin A to (-) -saframycin Mx type compound with the structure proposed for saframycin E. Chem Pharm Bull (Tokyo) . 1995 May;43 (5) :777-82.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6332217-01 0.1 mL
PDE7B, CT (PDE7B, cAMP-specific 3',5'-cyclic phosphodiesterase 7B) (MaxLight 550)
Ask
View Details 
MBS6332217-02 5x 0.1 mL
PDE7B, CT (PDE7B, cAMP-specific 3',5'-cyclic phosphodiesterase 7B) (MaxLight 550)
Ask
View Details 